208 related articles for article (PubMed ID: 31589186)
1. Primary vitreoretinal lymphoma: empowering our clinical suspicion.
Takhar JS; Doan TA; Gonzales JA
Curr Opin Ophthalmol; 2019 Nov; 30(6):491-499. PubMed ID: 31589186
[TBL] [Abstract][Full Text] [Related]
2. Potential Diagnosis of Vitreoretinal Lymphoma by Detection of MYD88 Mutation in Aqueous Humor With Ultrasensitive Droplet Digital Polymerase Chain Reaction.
Hiemcke-Jiwa LS; Ten Dam-van Loon NH; Leguit RJ; Nierkens S; Ossewaarde-van Norel J; de Boer JH; Roholl FF; de Weger RA; Huibers MMH; de Groot-Mijnes JDF; Kuiper JJW
JAMA Ophthalmol; 2018 Oct; 136(10):1098-1104. PubMed ID: 30027272
[TBL] [Abstract][Full Text] [Related]
3. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
[TBL] [Abstract][Full Text] [Related]
4. Vitreoretinal Lymphoma: A Literature Review and Introduction of a New Diagnostic Method.
Takhar J; Doan T; Gonzales JA
Asia Pac J Ophthalmol (Phila); 2021 Jan; 10(1):93-98. PubMed ID: 33481398
[TBL] [Abstract][Full Text] [Related]
5. [Isolated primary vitreoretinal lymphoma (case report)].
Stoyukhina AS; Korobov EN; Smolin SA
Vestn Oftalmol; 2024; 140(2. Vyp. 2):94-101. PubMed ID: 38739137
[TBL] [Abstract][Full Text] [Related]
6. CLINICAL FEATURES, DIAGNOSTIC SIGNIFICANCE, AND PROGNOSIS OF VITREORETINAL LYMPHOMA IN YOUNG PATIENTS.
Liu S; Gu J; Zhang T; Ping B; Zhou M; Huang X; Jiang R; Xu G; Chang Q
Retina; 2021 Dec; 41(12):2596-2604. PubMed ID: 34173362
[TBL] [Abstract][Full Text] [Related]
7. Consensus Recommendations for the Diagnosis of Vitreoretinal Lymphoma.
Carbonell D; Mahajan S; Chee SP; Sobolewska B; Agrawal R; Bülow T; Gupta V; Jones NP; Accorinti M; Agarwal M; Batchelor T; Biswas J; Cimino L; tenDam-van Loon NH; de-la-Torre A; Frenkel S; Pe'er J; Kramer M; Miserocchi E; Mochizuki M; Ness T; Rosenbaum JT; Sen HN; Simion M; Sitter H; Vasconcelos-Santos DV; Habot-Wilner Z; Coupland SE; Pulido JS; Smith J; Thorne JE; Zierhut M;
Ocul Immunol Inflamm; 2021 Apr; 29(3):507-520. PubMed ID: 34009095
[TBL] [Abstract][Full Text] [Related]
8. Clinical Relevance of the High Prevalence of MYD88 L265P Mutated Vitreoretinal Lymphoma Identified by Droplet Digital Polymerase Chain Reaction.
Shi H; Zhou X; Chen B; Xiao J; Li Y; Zhou X; Zhou Q; Chen K; Wang Q
Ocul Immunol Inflamm; 2021 Apr; 29(3):448-455. PubMed ID: 31603365
[No Abstract] [Full Text] [Related]
9.
Narasimhan S; Joshi M; Parameswaran S; Rishi P; Khetan V; Ganesan S; Biswas J; Sundaram N; Sreenivasan J; Verma S; Krishnamurthy V; Subramanian K
Indian J Ophthalmol; 2020 Oct; 68(10):2160-2165. PubMed ID: 32971631
[TBL] [Abstract][Full Text] [Related]
10. Clinical Experience in a Large Cohort of Patients with Vitreoretinal Lymphoma in a Single Center.
Giuffrè C; Cicinelli MV; Marchese A; Modorati GM; Brambati M; Ferreri AJM; Calimeri T; Ponzoni M; Bandello F; Miserocchi E
Ocul Immunol Inflamm; 2021 Apr; 29(3):472-478. PubMed ID: 32845738
[No Abstract] [Full Text] [Related]
11. Diagnostic methods for primary vitreoretinal lymphoma: A systematic review.
Huang RS; Mihalache A; Popovic MM; Cruz-Pimentel M; Pandya BU; Muni RH; Kertes PJ
Surv Ophthalmol; 2024; 69(3):456-464. PubMed ID: 38163550
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical and Immunocytochemical Analyses in Patients with Vitreoretinal Lymphoma.
Kase S; Namba K; Kanno-Okada H; Onozawa M; Hidaka D; Iwata D; Mizuuchi K; Fukuhara T; Fukuhara J; Kitaichi N; Matsuno Y; Ishida S
Ocul Immunol Inflamm; 2020; 28(1):147-155. PubMed ID: 30335535
[No Abstract] [Full Text] [Related]
13. Single B-Cell Genomic Analyses Differentiate Vitreoretinal Lymphoma from Chronic Inflammation.
Tan WJ; Wang MM; Castagnoli PR; Tang T; Chan ASY; Lim TS
Ophthalmology; 2021 Jul; 128(7):1079-1090. PubMed ID: 33221324
[TBL] [Abstract][Full Text] [Related]
14. PreservCyt Is an Optimal Fixative that Permits Cytologic and Molecular Analyses of Vitreoretinal Lymphoma Biopsies.
Wang MM; Tan WJ; Lim TS; Chan ASY
Ocul Immunol Inflamm; 2021 Apr; 29(3):430-439. PubMed ID: 31418635
[No Abstract] [Full Text] [Related]
15. Diagnosis and management of vitreoretinal lymphoma: present and future treatment perspectives.
Kaburaki T; Taoka K
Jpn J Ophthalmol; 2023 Jul; 67(4):363-381. PubMed ID: 37209195
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic efficacy of cell block method for vitreoretinal lymphoma.
Kase S; Namba K; Iwata D; Mizuuchi K; Kitaichi N; Tagawa Y; Okada-Kanno H; Matsuno Y; Ishida S
Diagn Pathol; 2016 Mar; 11():29. PubMed ID: 26987877
[TBL] [Abstract][Full Text] [Related]
17. Clinical Characteristics of Primary Vitreoretinal Lymphoma in an Indian Population.
Mahajan S; Nijhawan R; Rajwanshi A; Karkhur S; Mulkutar S; Dogra M; Lal V; Gupta V; Gupta A
Ocul Immunol Inflamm; 2017 Oct; 25(5):633-638. PubMed ID: 27003620
[TBL] [Abstract][Full Text] [Related]
18. Molecular profiling of vitreous fluid by massively parallel sequencing: a case series.
Hirschhorn JW; Snider JS; Lindsey KG; Schandl CA
J Am Soc Cytopathol; 2020; 9(4):254-257. PubMed ID: 32423686
[TBL] [Abstract][Full Text] [Related]
19. Features of Retinitis-like Lesions in Vitreoretinal Lymphoma.
Marchese A; Agarwal A; Miserocchi E; Giuffrè C; Bandello F; Modorati G; Prakash G; Gupta N; Bosello F; Sharma SP; Gupta V
Ocul Immunol Inflamm; 2021 Apr; 29(3):440-447. PubMed ID: 31567000
[No Abstract] [Full Text] [Related]
20. [Molecular diagnostics for vitreoretinal lymphoma].
Bonzheim I; Salmerón-Villalobos J; Süsskind D; Szurman P; Gekeler F; Spitzer MS; Salaverria I; Campo E; Coupland SE; Quintanilla-Martinez L; Fend F
Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):150-154. PubMed ID: 37947807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
